Dental Tribune U.S. Edition

Dental Tribune U.S. Edition | September 2014 a5Industry News Ad Across the five-decade observation period, edentulism prevalence declined from 18.9 percent in 1957–1958 to 4.9 percent in 2009–2012. The single most influential determinant of the decline was the passing of generations born be- fore the 1940s, whose rate of edentulism incidence (5–6 percent per decade of age) far exceeded that of later cohorts (1–3 percent per decade of age). High-income households experienced a greater rela- tive decline, but a smaller absolute de- cline, than did low-income households. By 2010, edentulism was a rare condi- tion in high-income households and had contracted geographically to states with disproportionately high poverty. With the passing of generations born in the mid-20th century, the rate of decline in edentulism is projected to slow, reach- ing 2.6 percent (95 percent prediction limits: 2.1 percent, 3.1 percent) by 2050. The continuing decline will be offset only partially by population growth and population aging, such that the predict- ed number of edentulous people in 2050 (8.6 million; 95 percent prediction limits: 6.8 million, 10.3 million) will be 30 per- cent lower than the 12.2 million edentu- lous people in 2010. “While it’s encouraging to know that this study by Dr. Gary Slade illustrates a steep decline in U.S. edentulism over the past five decades, these health gains in absolute terms have not been distributed equally,” said American Association for Dental Research President Dr. Timothy DeRouen. “Additional public health mea- sures must be taken to reduce tooth loss in low-income populations.” The paper, titled “Projections of U.S. Edentulism Prevalence Following Five Decades of Decline,” was published on- line on Aug. 21 in the Journal of Dental Research ahead of print. The journal is a publication of the International Asso- ciation for Dental Research (IADR) and the American Association for Dental Re- search, a division of the IADR. The IADR is a nonprofit organization dedicated to advancing research and increasing knowledge for the improvement of oral health, among other objectives. (Sources: University of North Carolina at Chapel Hill and the International Association for Dental Research) “ EDENTULISM, page A2 By DENTSPLY Pharmaceutical Staff For more than 100 years DENTSPLY In- ternational has been supporting dentists worldwide in their profession. The company’s trusted and compre- hensive range of anesthetics enables dentists and hygienists to start every procedure right. DENTSPLY Pharmaceu- tical ensures quality at each step of the product’s journey — from collection of active molecules all the way through to when the packages arrive at your office. Each cartridge is twice sterilized with sterilizing filter followed by autoclave method. Cartridges are then visually inspected with electronic laser for defects and im- purities, including but not limited to: cracks, foreign particles, color and den- sity, et al. Each cartridge is mylar-pack labeled to restrain the individual pieces in case of a break — thus avoiding any injuries. Each set of 10 cartridges is then blister packed to avoid breakage. Finally, each cartridge is color coded as per industry standard ADA system. DENTSPLY Pharmaceutical controls quality at every step, all the way to your office door Ensuring quality of DENTSPLY pharmaceuticals begins when collecting active molecules and continues through double-sterlization of cartridges, laser inspection for defects, safety- focused individual packaging and breakage-avoidance shipping. Photo/DENTSPLY International AAP BOOTH NO. 809 Obsessive quality control starts at molecular level

Dental Tribune U.S. Edition

Seitenübersicht